Académique Documents
Professionnel Documents
Culture Documents
40
Garattini et al. 41
42 Garattini et al.
Table I. Initial composition of the Bionator III group and control group
Sex
Observation period
length
Initial age
Wits index
Group
Male
Female
Mean
(months)
SD
(months)
Mean
(months)
SD
(months)
Mean
SD
SE
Bionator
Control
15
15
24
24
94.9
94
20
20
24.3
24
1.2
1
25.3
1.7
1.9
0.9
0.3
0.1
(N-Me 1 1.5 mm, Table III). Reduced anteroposterior mandibular growth (Go-Me 21.1 mm, S-N/
Go-Me 1 1.6, PNSog 21, Table III) and the
variation of the anteroposterior relationships between the upper and the lower jaw were noticed
(Wits 1 2.4 mm, Table III).
The ANOVA test was performed to assess the
significance of the therapeutic changes according to
the skeletal pattern, determined by the anterior
facial height/posterior facial height ratio (S-Go/NMe). This test showed that therapeutical changes
ANS
SNB
ANB
S-N
Pns-A
WITS
Convessita`
Pns-Ans
Go-Me
PNSog
Ba-A
Ar-Pog
S-N/Go-Me
Ar-Go anat
N-Me
N-Ans
Ans-Me
S-Go
S-Go/N-Me
ArGoMe geo
Som. Jarabak
S-NGo-Gn
Pns-AnsGo-Gn
S-NPns-Ans
IS-N
IGo-Gn
EL-Ls Rik
EL-Li Rik
CmSnLs
Control group
Initial
Final
Difference
SD
SE
Significance
Initial
Final
Difference
SD
SE
79.9
78.5
1.4
66.3
41.6
25.3
1.2
45.9
66.3
78.6
85.4
96.7
99.8
40.2
107.8
46.5
62.6
67.1
60.8
130.5
395.2
35.9
28.9
7
102.3
87.8
23.4
21.3
115.3
81.1
77.7
3.5
67.9
44.6
22.5
2.9
48.8
68.6
78.4
89.6
100.5
98.2
41.5
113.4
49.6
65.7
70.3
60.7
129.5
396
36.8
28.9
7.8
97.9
84.2
23.2
22.2
116
1.2
20.8
2
1.6
3
2.7
1.7
2.9
2.3
20.3
4.2
3.8
21.6
1.4
5.6
3
3.1
3.2
20.1
21
0.8
0.9
e
0.9
24.3
23.6
0.2
1
0.7
2.4
1.7
2
1
1.8
1.9
1.5
1.2
1.9
1.6
1.8
2.1
4
2
2.6
2.3
1.6
1.4
1.7
2.6
2.4
2.4
2.1
2.5
15.2
7.9
2
1.6
9
0.4
0.3
0.3
0.2
0.3
0.3
0.2
0.2
0.3
0.3
0.3
0.3
0.6
0.3
0.4
0.4
0.3
0.2
0.3
0.4
0.4
0.4
0.3
0.4
2.9
1.5
0.3
0.2
1.4
S**
S**
S***
S***
S***
S***
S***
S***
S***
NS
S***
S***
S*
S***
S***
S***
S***
S***
NS
S*
NS
S*
NS
S*
NS
S*
NS
S*
NS
79.6
76.7
3.6
62.6
41.2
1.7
2.7
44.9
58.9
76.7
81.2
87.6
106.3
36.3
98.7
44
56.1
60.9
61.7
132.4
396.7
36.7
29.7
7
101.2
89.1
22.2
21.9
109.7
79.6
76.6
3.2
64.1
42.6
2
2.2
46.4
62.3
77.4
83.5
91.7
103
37.7
102.7
46.3
57.7
63.8
62.1
131.4
396.1
36.2
29
7.1
102.2
90.6
22.6
22
110.5
20.1
20.1
20.4
1.6
1.4
0.3
20.5
1.5
3.4
0.8
2.3
4
23.3
1.4
4
2.3
1.6
2.9
0.4
21
20.5
20.5
20.6
0.1
1.1
1.5
20.4
20.1
0.8
0.2
2.2
0.3
0.3
0.6
0.9
0.2
0.1
0.8
0.2
0.2
0.3
1.3
0.5
0.5
0.4
0.3
0.3
0.4
0.2
0.4
0.4
0.3
0.2
1.2
1
0.2
0.2
1.4
e
0.4
e
e
0.1
0.1
e
e
0.1
e
e
0.9
0.2
0.1
0.1
0.1
e
e
1
e
0.1
0.1
0.1
e
0.2
0.2
e
e
0.2
Garattini et al. 43
Mean
difference
SD
SE
Significance of
difference
20.1
0.7
1.5
1.5
0.3
1
2.2
1.6
2.5
1.4
0.2
0.4
0.2
0.4
0.2
N.S.
N.S.
S.***
S.**
N.S.
20.5
1.7
0.3
N.S.
1.3
2.3
0.4
S.**
1.6
1.4
1.9
1.7
1.3
1.8
0.3
0.2
0.3
S.*
S.**
S.*
1.3
20.7
0.6
20.1
2.4
2.5
2
2
0.4
0.4
0.3
0.3
S.**
N.S.
N.S.
N.S.
20.3
21.1
0.0
2.1
1.9
2.0
0.3
0.3
0.3
N.S.
S.**
N.S.
20.7
21.0
0.0
1.3
2.6
1.5
2.6
2.2
0.4
0.2
0.4
0.4
S*
S.***
N.S.
S.***
1.6
3.9
0.6
S.**
2.4
2.1
0.3
S.***
2.5
2.2
0.7
2.0
1.5
2.1
0.3
0.2
0.3
S.***
S.***
N.S.
DISCUSSION
Table IV. Analysis of the variance (Anova test) according to skeletal pattern in the Bionator III group
Difference between the groups
Number of
cases
F-test
Hypodivergent
19
Normodivergent
14
Hyperdivergent
6
Fischers test PLSD
Hypodivergent vs Normodivergent
*95% significance.
Pns-Ans
(mean of the
differences)
Pns-A
(mean of the
differences)
Ar-Go
(mean of the
differences)
Wits
(mean of the
differences)
2.3
p 5 0.0492
13.2
12.4
13.1
0.8*
4.3
p 5 0.0209
13.7
12.1
13.0
1.2*
3.2
p 5 0.0483
12.2
10.2
11.4
1.4*
4.3
p 5 0.0208
23.5
21.7
22.8
1.3*
44 Garattini et al.